Giuseppe Barone Selected Research

Giuseppe Barone Research Topics

Disease

20	Neuroblastoma 01/2024 - 10/2005
18	Neoplasms (Cancer) 10/2022 - 03/2007
2	Heart Failure 01/2024 - 11/2023
2	Hypersensitivity (Allergy) 11/2021 - 01/2021
2	Pain (Aches) 11/2021 - 01/2021
2	Osteoporosis 08/2021 - 01/2020
2	Brain Neoplasms (Brain Tumor) 05/2011 - 07/2006
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2024
1	Atrial Fibrillation 01/2024
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2024
1	Pulmonary Hypertension 01/2024
1	Scoliosis 12/2023
1	Dementia (Dementias) 11/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Hypotension (Low Blood Pressure) 11/2023
1	Edema (Dropsy) 11/2023
1	Cardiogenic Shock 12/2022
1	Osteoarthritis 09/2022
1	Fever (Fevers) 11/2021
1	Capillary Leak Syndrome 11/2021
1	Metabolic Bone Diseases (Osteopenia) 08/2021
1	Obesity 01/2021
1	Cytokine Release Syndrome 11/2020
1	Bone Marrow Diseases (Bone Marrow Disease) 11/2020
1	Bone Resorption 01/2020
1	Fibrosis (Cirrhosis) 11/2019
1	Epidural Abscess 01/2019
1	Abscess 01/2019
1	Hemorrhage 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 10/2014
1	Dropped Head Syndrome 10/2014
1	Primitive Neuroectodermal Tumors (PNET) 05/2014
1	Medulloblastoma 05/2014
1	Sarcoma (Soft Tissue Sarcoma) 01/2014

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 07/2006
4	mesoglycanIBA 01/2022 - 01/2020
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2024 - 10/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 10/2005
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022 - 01/2017
2	AntibodiesIBA 11/2021 - 01/2019
2	Chimeric Antigen ReceptorsIBA 11/2020 - 01/2019
2	RetinoidsIBA 08/2012 - 03/2007
2	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 08/2012 - 03/2007
2	Nerve Growth Factor (NGF)IBA 07/2011 - 09/2009
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2009 - 12/2008
1	Furosemide (Lasix)FDA LinkGeneric 01/2024
1	Bevacizumab (Avastin)FDA Link 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Natriuretic PeptidesIBA 11/2023
1	DiureticsIBA 11/2023
1	cyclopropapyrroloindoleIBA 12/2022
1	Anaplastic Lymphoma KinaseIBA 10/2022
1	SolutionsIBA 09/2022
1	EnzymesIBA 01/2022
1	AntioxidantsIBA 01/2022
1	dinutuximabIBA 11/2021
1	CytokinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 11/2020
1	fludarabineIBA 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	CYC065IBA 11/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	vistusertibIBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	MLN 8237IBA 01/2020
1	Aurora Kinase AIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Serum-Free Culture MediaIBA 01/2019
1	cediranib (AZD2171)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Checkpoint Kinase 1IBA 01/2017
1	Aurora KinasesIBA 01/2017
1	Biological FactorsIBA 10/2016
1	ImidazolinesIBA 01/2014
1	Oncogene Proteins (Oncogene Protein)IBA 11/2013

Therapy/Procedure

12	Therapeutics 11/2023 - 07/2011
5	Drug Therapy (Chemotherapy) 01/2024 - 11/2019
3	Catheters 12/2022 - 07/2010
3	Immunotherapy 11/2021 - 02/2013
3	Precision Medicine 01/2020 - 01/2019
2	Radiotherapy 11/2021 - 10/2014
2	Investigational Therapies (Experimental Therapy) 01/2020 - 01/2017
1	Heart Transplantation (Grafting, Heart) 01/2024
1	Reoperation 12/2023
1	Prostheses and Implants (Prosthesis) 09/2022
1	Resistance Training 01/2022
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021
1	Operative Surgical Procedures 01/2021
1	Surgical Decompression 01/2019
1	Minimally Invasive Surgical Procedures 01/2019
1	Laminectomy 01/2019
1	Osteotomy 10/2014